Organization
Best Healthcare
1 clinical trial
Clinical trial
Open Label Study to Assess the ~32-Year Persistence of Hepatitis A Antibody Among Participants in the Pivotal, Double-Blind, Placebo-Controlled Efficacy Study of VAQTA (Study 023-001)Status: Not yet recruiting, Estimated PCD: 2025-03-01